Healthcare - Press Releases

STOCKHOLM, Feb. 12, 2025 /PRNewswire/ -- The Board of Directors of Medicover AB (publ) ("Medicover") today announces that John Stubbington will succeed Fredrik Rgmark as new CEO of the Medicover group from 1 May 2025.

STOCKHOLM, Feb. 12, 2025 /PRNewswire/ -- Fourth quarter

- Ajinomoto Co., Inc., a travs de su subsidiaria Ajinomoto Health & Nutrition North America, Inc., anuncia el patrocinio de oro de LabCentral: Acelerando la innovacin en biotecnologa

SANDNES, Norway, Feb. 12, 2025 /PRNewswire/ -- Desert Control AS (DSRT) announces its fourth quarter report and interim full-year financial results for the fiscal period ending 31 December 2024.

PARS, 11 de febrero de 2025 /PRNewswire/ -- El Congreso Mundial IMCAS 2025, el mayor congreso cientfico de esttica del mundo, se celebr a lo grande en Pars del 30 de enero al 1 de febrero, celebrando su 26 aniversario.

SALT LAKE CITY, Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its underwritten public offering of 1,250,000 shares of its Class A common stock at a public offering price of $4.00 per share, and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase 11,250,000 shares of its Class A common stock at a public offering price of $3.9999 per pre-funded warrant, which equals the public offering price per share of the Class A common stock less the $0.0001 per share exercise price of each pre-funded warrant, in each case before underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sera, are expected to be approximately $50 million. Sera has granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The pre-funded warrants will be immediately exercisable, and may be exercised at any time after their original issuance. All of the shares and pre-funded warrants are being offered by Sera. The offering is expected to close on February 12, 2025, subject to the satisfaction of customary closing conditions.

PARIS, 11. Februar 2025 /PRNewswire/ -- Der IMCAS-Weltkongress 2025, der weltweit grte wissenschaftliche sthetikkongress, fand vom 30. Januar bis 1. Februar in Paris statt und feierte damit sein 26-jhriges Bestehen.

PARIS, 11 fvrier 2025 /PRNewswire/ -- Le congrs mondial 2025 de l'IMCAS, le plus grand congrs scientifique d'esthtique au monde, s'est tenu avec faste Paris du 30 janvier au 1er fvrier, clbrant ainsi son 26e anniversaire.

DUBAI, UAE, Feb. 11, 2025 /PRNewswire/ -- The future of healthcare guidance is here. The revolutionaryXRPH AI App, built to evolve and continually learn, has officially launched and is available for free download on Google Play, the App Store, and directly via XRPH.ai.

LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the latest step in Bio X Cell's growing international presence, complementing its flagship distribution center in Germany, as well as partnerships that extend the Bio X Cell name to Singapore and Korea, along with its headquarters and manufacturing facility in New Hampshire.

LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the latest step in Bio X Cell's growing international presence, complementing its flagship distribution center in Germany, as well as partnerships that extend the Bio X Cell name to Singapore and Korea, along with its headquarters and manufacturing facility in New Hampshire.

ABU DHABI, UAE, Feb. 11, 2025 /PRNewswire/ -- PureHealth Holding PJSC ("PureHealth" or "the Group") (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the period ended 31 December 2024. The Group recorded a strong revenue increase of 58% year-on-year to AED 25.8 billion in FY-2024, driven by robust growth across its core segments, including Hospitals, Insurance and Procurement; and was further strengthened by the successful integration of strategic acquisitions. The Group's strong performance reflected positively on profitability, with EBITDA growing 69% year-on-year to AED 4.1 billion and net profit increasing by 78% year-on-year to AED 1.7 billion in FY-2024.

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global wearable technology marketsize is estimated to grow by USD 99.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over17.3% during the forecast period. Popularity of wearable devices as a payment methodis driving market growth,with a trend towardsdevelopment of low-power electronics. However,rising penetration of counterfeit products poses a challenge. Key market players include Apple Inc., ASUSTeK Computer Inc., BAE Systems Plc, CINOPTICS, Citizen Watch Co. Ltd., Elbit Systems Ltd., Garmin Ltd., Google LLC, Huawei Technologies Co. Ltd., Kopin Corp., Lenovo Group Ltd., LG Corp., Magic Leap Inc., Misfit Inc., Polar Electro Oy, Samsung Electronics Co. Ltd., Sony Semiconductor Israel Ltd., Tex Ray Industrial Co. Ltd., Vuzix Corp., and Xiaomi Inc..

LINKPING, Sweden, Feb. 11, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) announces that Region Vstra Gtaland, Sweden's second largest healthcare region, will use Sectra's digital pathology solution. This marks an expansion of a more than 20-year collaboration for medical imaging between the healthcare provider and Sectra. The digital pathology solution will enable the hospitals, that also use Sectra for radiology, to efficiently carry out the entire imaging diagnostic process within a single application, while also providing tools for enhanced collaboration. This will contribute to improved diagnostic accuracy and speed of treatment, with the goal of improving especially cancer care in the region.

YONGIN, South Korea, Feb. 11, 2025 /PRNewswire/ --GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held from Feb. 3rd to 7th, 2025, in San Diego, USA.

WILMINGTON, N.C., Feb. 11, 2025 /PRNewswire/ -- Frontier Scientific Solutions is excited to announce that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This groundbreaking project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in North America, further solidifying Wilmington's position as a critical hub for the global life sciences supply chain.

WILMINGTON, N.C., Feb. 11, 2025 /PRNewswire/ -- Frontier Scientific Solutions is excited to announce that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This groundbreaking project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in North America, further solidifying Wilmington's position as a critical hub for the global life sciences supply chain.

NEW YORK and LONDON and MUNICH and NEW DELHI, Feb. 11, 2025 /PRNewswire/ --Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precision treatment. Dr. Cristofanilli, an expert in circulating tumor cells, biomarkers, and molecular profiling, will collaborate with DCG to develop innovative solutions for early and accurate cancer detection and treatment personalization.

PAPHOS, Cyprus, Feb. 11, 2025 /PRNewswire/ -- ILIKOS Consulting Group and Jordan Center for Pharmaceutical Research (JCPR) Announce Strategic Partnership to highlight significant advantages in designing and executing BE/BA studies in Jordan and advancing innovative clinical research across the country

Success for Riyadh Active Industry, Riyadh Muscle Show and the Riyadh Active Exhibition under the signature of Italian Exhibition Group

Erfolg fr die Riyadh Active Industry, die Riyadh Muscle Show und die Riyadh Active Exhibition unter der Schirmherrschaft der Italian Exhibition Group

Succs pour Riyadh Active Industry, Riyadh Muscle Show et Riyadh Active Exhibition sous la signature d'Italian Exhibition Group

Success for Riyadh Active Industry, Riyadh Muscle Show and the Riyadh Active Exhibition under the signature of Italian Exhibition Group

Nonprofit calls on VA Secretary Doug Collins to launch an immediate investigation on budget allocation

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global Assistive technology (AT) marketsize is estimated to grow by USD 6.3 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 4.5% during the forecast period. Rising number of orthopedic and neurological disordersis driving market growth,with a trend towardsgrowing consumer awareness of health and wellness in urban areas. However,high cost of mobility products poses a challenge. Key market players include Boundless Assistive Technology LLC, Demant AS, Freedom Scientific Inc., GF Health Products Inc., GN Store Nord AS, Invacare Corp., Karma Medical Products Co. Ltd., MED EL Medical Electronics., Medical Depot Inc., Medline Industries LP, NOVA Medical Products, Ossenberg GmbH, Ostrich Mobility Instruments Pvt. Ltd., Ottobock SE and Co. KGaA, Permobil AB, Persona Medical, Pride Mobility Products Corp., Sonova AG, Starkey Laboratories Inc., and Sunrise Medical LLC.